Abstract
Resistant hypertension affects a minority of treated hypertensive patients, yet the resulting target organ damage causes disproportionate morbidity and increased risk of cardiovascular events. The clinical features and efforts to adjust drug treatment in a resistant hypertensive patient are described. As demonstrated, serial hemodynamic measurements using thoracic bioimpedance may provide a rationale for selection of effective combination antihypertensive therapy. (CHF. 2000)
Original language | English (US) |
---|---|
Pages (from-to) | 90-93 |
Number of pages | 4 |
Journal | Congestive Heart Failure |
Volume | 6 |
Issue number | 2 |
DOIs | |
State | Published - Jan 1 2000 |
ASJC Scopus subject areas
- Emergency Medicine
- Emergency
- Cardiology and Cardiovascular Medicine